€2.1 million has been granted to a consortium led by Fortis Medical Devices, a client of Údarás na Gaeltachta, in conjunction with RCSI University of Medicine and Health Sciences, and Smart Electronics.
Fortis Medical Devices, a spinoff of the University of Galway, based in Spiddal, will be able to make significant progress in the development of cueStim–Stroke, with the grant which has been awarded to the consortium through the Department of Enterprise, Trade and Employment’s Disruptive Technologies Innovation Fund (DTIF).
Thomas Gutierrez, Chief Executive, Fortis Medical Devices, said: “Our mission is to significantly improve the quality of life for stroke survivors. With this DTIF award, we can accelerate the development of cueStim-Stroke to bring real-world solutions to patients and clinicians.”
Tomás Ó Síocháin, Chief Executive, Údarás na Gaeltachta, said: “We are extremely proud of this achievement by Fortis Medical Devices, a client company of Údarás na Gaeltachta. This is an excellent example of the innovation and entrepreneurship taking place in the Gaeltacht. This DTIF grant demonstrates the potential of Gaeltacht companies to develop groundbreaking technologies with global impact, while creating employment and economic growth in our communities.”
Through the grant, the consortium will further develop cueStim–Stroke, a new wearable device for patients affected by post-stroke gait irregularities.